TRI-2-2

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameTRI-2-2
Drug Alias NameTRI2-2TRI-2-2
ClassificationOther
Mechanisms of ActionAngiotensin-converting enzyme 2 inhibitors
TargetsAngiotensin-converting enzyme 2
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A